Showing results (691-700 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Strategic use of plasma and microsome binding to exploit in vitro clearance in early drug discoveryGeorge Chang, Stefanus J Steyn, John P Umland, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Exploring target-selectivity patterns of molecular scaffoldsYe Hu, Jürgen Bajorath
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease InhibitorAshok Arasappan, Frank Bennett, Stephane L Bogen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel AntagonistsJames C Barrow, Kenneth E Rittle, Thomas S Reger, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and In Vitro Evaluation of Imidazo[1,2-b]pyridazines as Ligands for β-Amyloid PlaquesFanxing Zeng, David Alagille, Gilles D Tamagnan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of NVP-LDE225, a Potent and Selective Smoothened AntagonistShifeng Pan, Xu Wu, Jiqing Jiang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of novel urease inhibitors by high-throughput virtual and in vitro screeningObaid-Ur-Rahman Abid, Tariq Mahmood Babar, Farukh Iftakhar Ali, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulatorsScott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
KSRP/FUBP2 Is a Binding Protein of GO-Y086, a Cytotoxic Curcumin AnalogueHiroyuki Yamakoshi, Naoki Kanoh, Chieko Kudo, et al.
Pageof 438